Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Thymogen vs ARA-290

    Side-by-side comparison of Thymogen and ARA-290: mechanism, half-life, dose range, safety profile, and vendor pricing.

    Thymogen: no price on file
    ARA-290 from $32.00

    Price snapshot

    Thymogen

    Current low
    —
     
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    ARA-290

    Current low
    $32.00
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    Thymogen

    Thymogen (also transliterated Timogen or ╨ó╨╕╨╝╨╛╨│╨╡╨╜) is a synthetic dipeptide — glutamyl-tryptophan (Glu-Trp, or EW) — developed by the St Petersburg Institute of Bioregulation and Gerontology under Professor…

    No vendor price on file.

    Full Thymogen profile

    ARA-290

    ARA-290, also known as Cibinetide or pHBSP (Helix B Surface Peptide), is an 11-amino-acid peptide — QEQLERALNSS — designed to mimic a specific region of the tissue-protective surface of erythropoietin (EPO) without…

    Lowest listed price: $32.00 across 5 listings

    Full ARA-290 profile

    Side-by-side comparison

    Attribute Thymogen ARA-290
    Category Recovery Recovery
    Research Stage Approved in Russia / not Western-validated Phase 2
    Mechanism of Action Thymogen's proposed mechanism is best understood in the context of thymic biology and the broader class of thymic peptide immunomodulators. The thymus is the primary organ of T-cell maturation - T-cell progenitors from bone marrow migrate to the thymus,… ARA-290's mechanism of action is one of the more elegantly engineered examples of pharmaceutical design in the peptide space. Understanding it requires appreciation of the dual-receptor biology of erythropoietin and the specific receptor-selective engineering…
    Half-Life short; not well characterized ~2 minutes (plasma half-life; downstream tissue-protective effects persist hours to days)
    Typical Dose Range 50-100 mcg intranasal per nostril 1-2x/day, or 100 mcg SC once daily; 10-day courses, 2-4x/year 1 mg - 4 mg subcutaneous daily
    Dosing Frequency — Once daily
    Administration — —
    Side Effects Thymogen's side-effect profile in the Russian clinical literature is described as mild and infrequent, consistent with its long history of registered pharmaceutical use in Russia. Users should weight this with modest skepticism given the limitations of the… ARA-290 has demonstrated a notably favorable safety profile across clinical trials — one of the cleaner safety records among research peptides. The engineering rationale of separating tissue-protective effects from hematopoietic effects appears to have largely…
    Molecular Weight ~333.3 g/mol (Glu-Trp) ~1257 Da
    Common Vial Sizes — —

    Price History

    3 data points
    • Ion Peptide
    • BHG Labs
    • LB

    Thymogen: potential benefits

    • Immune system modulation
    • Thymic function restoration
    • Enhanced T-cell immunity
    • Immune anti-aging support

    ARA-290: potential benefits

    • Neuroprotective effects
    • Anti-inflammatory activity
    • Tissue repair without erythropoiesis
    • Potential diabetic neuropathy treatment
    • Sarcoidosis symptom reduction

    Frequently asked

    What's the difference between Thymogen and ARA-290?

    Thymogen is a recovery that thymogen's proposed mechanism is best understood in the context of thymic biology and the broader class of thymic peptide immunomodulators. the thymus is the primary organ of…. ARA-290 is a recovery that ara-290's mechanism of action is one of the more elegantly engineered examples of pharmaceutical design in the peptide space. understanding it requires appreciation of the…. The two differ in mechanism, half-life (short; not well characterized vs ~2 minutes (plasma half-life; downstream tissue-protective effects persist hours to days)), and typical dose range.

    Which has the longer half-life, Thymogen or ARA-290?

    Thymogen has a half-life of short; not well characterized. ARA-290 has a half-life of ~2 minutes (plasma half-life; downstream tissue-protective effects persist hours to days). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.

    Can you stack Thymogen and ARA-290?

    Stacking depends on mechanism overlap, safety profile, and goals. Thymogen and ARA-290 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.

    See current vendor prices

    Listings from the vendors we track. Prices change often, so check the vendor before you buy.

    Thymogen prices ARA-290 prices Compare all compounds

    Before you buy Thymogen or ARA-290

    Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.

    View Vendor Scorecard

    Related comparisons

    Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.